# Intestinal Microbiome Transplant in ALS

> **NCT07017946** · PHASE1,PHASE2 · RECRUITING · sponsor: **Duke University** · enrollment: 20 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis ALS

## Interventions

- **DRUG:** MTP-101C

## Key facts

- **NCT ID:** NCT07017946
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07017946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07017946, "Intestinal Microbiome Transplant in ALS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07017946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*